G. Katsifis

发表

Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives

G. Kitas, G. Kolovou, S. Mavrogeni, 2018, Rheumatology International.

Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus.

J. Ioannidis, A. Tzioufas, H. Moutsopoulos, 2002, Rheumatology.

Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus.

J. Ioannidis, A. Tzioufas, H. Moutsopoulos, 2002, The Journal of rheumatology.

Myocardial perfusion in peripheral Raynaud's phenomenon. Evaluation using stress cardiovascular magnetic resonance.

G. Kolovou, S. Mavrogeni, K. Bratis, 2017, International journal of cardiology.

Is There a Brain/Heart Interaction in Rheumatoid Arthritis and Seronegative Spondyloartropathies? A Combined Brain/Heart Magnetic Resonance Imaging Reveals the Answer

G. Kitas, G. Kolovou, S. Mavrogeni, 2020, Current Rheumatology Reports.

Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance.

G. Kolovou, S. Mavrogeni, E. Gialafos, 2013, Inflammation & allergy drug targets.

Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide

A. Tzioufas, G. Katsifis, GE Katsifis, 2004, Lupus.

Current understanding and future perspectives of brain–heart–kidney axis in psoriatic arthritis

G. Kitas, G. Kolovou, S. Mavrogeni, 2020, Rheumatology International.

Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.

G. Kitas, G. Kolovou, S. Mavrogeni, 2019, International journal of cardiology.

Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria

G. Kolovou, S. Mavrogeni, M. Noutsias, 2017, BMC Cardiovascular Disorders.

Cardiovascular Magnetic Resonance Identifies High-Risk Systemic Sclerosis Patients with Normal Echocardiograms and Provides Incremental Prognostic Value

G. Kitas, G. Kolovou, S. Mavrogeni, 2019, Diagnostics.

Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)

G. Kolovou, S. Mavrogeni, P. Sfikakis, 2019, Rheumatology.

Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance.

G. Kitas, G. Kolovou, S. Mavrogeni, 2015, Inflammation & allergy drug targets.

Pseudo-infarction pattern in diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance.

G. Kitas, G. Kolovou, S. Mavrogeni, 2016, International journal of cardiology.

Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation

S. Pillemer, S. Wahl, N. Moutsopoulos, 2008, Annals of the rheumatic diseases.

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

Amit R. Patel, S. Gabriel, E. Nagel, 2016, International journal of cardiology.

Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients

G. Kitas, P. Sfikakis, A. Drosos, 2018, Mediterranean journal of rheumatology.

T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology

S. Wahl, N. Moutsopoulos, G. Katsifis, 2007, Clinical reviews in allergy & immunology.

Immunopathology and Infectious Diseases Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren ’ s Syndrome Immunopathogenesis

S. Pillemer, S. Wahl, N. Moutsopoulos, 2010 .

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus

G. Kolovou, V. Vartela, S. Mavrogeni, 2018, Lupus.

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.

G. Kitas, G. Kolovou, S. Mavrogeni, 2017, International journal of cardiology.

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases

G. Kitas, G. Kolovou, S. Mavrogeni, 2021, Mediterranean journal of rheumatology.

Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-Sectional Study

G. Kitas, G. Kolovou, S. Mavrogeni, 2020, Journal of clinical medicine.

The Double-Edged Sword of T1-Mapping in Systemic Sclerosis—A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance

G. Kitas, G. Kolovou, S. Mavrogeni, 2020, Diagnostics.

CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications

G. Kitas, G. Kolovou, S. Mavrogeni, 2019, PloS one.

Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study.

J. Ioannidis, H. Moutsopoulos, M. Manoussakis, 2003, Rheumatology.

Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus

C. Kallenberg, G. Kitas, G. Kolovou, 2020, Current cardiology reviews.

THU0355 PARAMETRIC CARDIAC MAGNETIC RESONANCE IMAGING IDENTIFIES ARRHYTHMOGENIC SUBSTRATES IN SYSTEMIC SCLEROSIS PATIENTS

J. Lima, G. Kitas, G. Kolovou, 2020, Annals of the Rheumatic Diseases.

Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.

S. Pillemer, G. Katsifis, Sofia Rekka, 2009, The American journal of pathology.